PRO: This Patient Should Have a Liver Biopsy

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2019 Oct 22

PMID 31632661

Citations 1

Authors

Akshata Moghe

Matthew Klinge

Naudia Jonassaint

Affiliations

Soon will be listed here.

Citing Articles

Efficacy and safety of elbasvir/grazoprevir treatment for Chinese patients with hepatitis C virus genotype 1b: a retrospective study.

Li J, Li G, Wang J, Zhao R, He J, Wang L Am J Transl Res. 2022; 14(6):3995-4005.

PMID: 35836873 PMC: 9274559.

References

Akay S, Karasu Z, Noyan A, Pala S, Musoglu A, Ilter T . Liver biopsy: is the pain for real or is it only the fear of it?. Dig Dis Sci. 2007; 52(2):579-81. DOI: 10.1007/s10620-006-9493-6. View

Lin J, Piper M, Perdue L, Rutter C, Webber E, OConnor E . Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016; 315(23):2576-94. DOI: 10.1001/jama.2016.3332. View

Vuppalanchi R, Unalp A, Van Natta M, Cummings O, Sandrasegaran K, Hameed T . Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol. 2009; 7(4):481-6. PMC: 2770348. DOI: 10.1016/j.cgh.2008.12.015. View

Rockey D, Caldwell S, Goodman Z, Nelson R, Smith A . Liver biopsy. Hepatology. 2009; 49(3):1017-44. DOI: 10.1002/hep.22742. View

Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View

Runyon B . Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013; 57(4):1651-3. DOI: 10.1002/hep.26359. View

Matteoni C, Younossi Z, Gramlich T, Boparai N, Liu Y, McCullough A . Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116(6):1413-9. DOI: 10.1016/s0016-5085(99)70506-8. View

Babu A, Wells M, Teytelboym O, Mackey J, Miller F, Yeh B . Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics. 2016; 36(7):1987-2006. PMC: 5584553. DOI: 10.1148/rg.2016160042. View

Loomba R, Sanyal A . The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013; 10(11):686-90. DOI: 10.1038/nrgastro.2013.171. View

10.

Wang L, Mannalithara A, Singh G, Ladabaum U . Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study. Gastroenterology. 2017; 154(3):540-555.e8. DOI: 10.1053/j.gastro.2017.10.006. View

11.

Vuppalanchi R, Siddiqui M, Van Natta M, Hallinan E, Brandman D, Kowdley K . Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2017; 67(1):134-144. PMC: 5739967. DOI: 10.1002/hep.29489. View

12.

Park C, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L . Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gastroenterology. 2016; 152(3):598-607.e2. PMC: 5285304. DOI: 10.1053/j.gastro.2016.10.026. View

13.

Sanyal A, Brunt E, Kleiner D, Kowdley K, Chalasani N, Lavine J . Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011; 54(1):344-53. PMC: 4014460. DOI: 10.1002/hep.24376. View